Counterfeit medicines remain one of the most dangerous threats to public health in Africa. The World Health Organization estimates that up to 20% of medicines sold on the continent are substandard or falsified, contributing to tens of thousands of preventable deaths each year. In Ethiopia, the challenge is particularly acute: remote distribution networks, limited regulatory oversight, and fragmented supply chains create fertile ground for illicit operators to introduce fake drugs into the market.
At Tonga Pharmaceuticals PLC, we believe technology is the most powerful weapon in this fight. Our commitment to patient safety goes far beyond manufacturing quality — it extends all the way to the moment a patient holds a medicine box in their hands. That is why we have invested in a dual-layer verification system combining blockchain-based serialization and QR-code authentication to guarantee the authenticity of every product we ship.
The Blockchain Layer
Every batch of Tonga Pharma medication is assigned a unique digital identifier recorded on a tamper-proof blockchain ledger. From the moment a batch leaves our Addis Ababa manufacturing facility, each handoff — to regional warehouses, to distributors, to pharmacies — is logged immutably. This means that regulators, pharmacists, and even patients can trace the full journey of a medicine box with absolute certainty. No record can be altered, no transaction can be erased. If a product does not appear in the chain, it did not come from us.
QR Verification at the Point of Care
Blockchain provides the backbone, but accessibility is everything. That is where our QR-based verification comes in. Each Tonga Pharma package features a unique QR code on its outer carton. Using any smartphone, a pharmacist or patient can scan the code and instantly confirm: the product is genuine, it was manufactured by Tonga Pharmaceuticals, it has not been tampered with, and its expiry date is valid. The verification result is returned in under two seconds, even on low-bandwidth connections common across Ethiopia's regions.
Impact on the Ground
Since deploying this system across our product lines in early 2024, we have seen measurable results. Distributor confidence has risen sharply — partners report fewer disputes and faster inventory reconciliation. More importantly, pharmacists in remote areas have told us that the QR scan gives them something that was previously hard to come by: certainty. When a health worker in Somali Region can verify a box of amoxicillin in seconds, patient trust grows, and counterfeit operators lose their foothold.
We are also working closely with the Ethiopian Food and Drug Authority (EFDA) to share anonymized verification data, helping regulators identify hotspots of counterfeit activity and allocate enforcement resources more effectively. This public-private collaboration is essential — no single company can solve this problem alone.
Looking Ahead
Our technology roadmap includes expanding the system to support SMS-based verification for feature phones, integrating AI-driven anomaly detection to flag suspicious scan patterns in real time, and open-sourcing parts of our verification protocol so that other Ethiopian manufacturers can adopt the same standards. We believe that transparency and shared infrastructure are not competitive disadvantages — they are public goods.
Combatting counterfeit medicines is not a solo endeavor. It requires manufacturers, regulators, distributors, pharmacists, and patients working in concert, armed with the right tools. At Tonga Pharmaceuticals, we are proud to be building those tools — and to be putting them in the hands of the people who need them most.